Dr Claire Kilty
Head of Research, Irish Cancer Society
We must support clinical trial research to ensure that Irish cancer patients have access to innovative and novel cancer treatments and approaches.
A key priority for the Irish Cancer Society is investing in world-class cancer research that will have an impact on people affected by cancer in Ireland.
Improving cancer care in Ireland
The Irish Cancer Society is the largest voluntary funder of cancer research in Ireland. Every year, we invest €3.7 million, on average, in over 100 researchers working all across the country to improve cancer outcomes.
We provide over €1 million of funding every year to Cancer Trials Ireland, the leading cancer research trials organisation in Ireland. Through this investment, the Cancer Trials Ireland team work hard to drive and attract a broad trial portfolio to Ireland across a range of cancer types.
Trials improve patient outcomes today
Each year in Ireland, thousands of people affected by cancer are participating in hundreds of clinical trials across the island. For some cancer patients, trials may be the best treatment option for them, especially those who may have exhausted previous treatment options.
In addition to trials focused on improving patient outcomes through new treatment modalities, we are also passionate about ensuring Irish patients have access to cutting-edge studies centred on improvements in their cancer care and quality of life. For example, trials focusing on diet and exercise interventions have shown success for some individuals living with and beyond cancer.
Trials focusing on diet and exercise interventions
have shown success for some individuals
living with and beyond cancer.
Research talent and expertise
Alongside a direct focus on cancer trials, it is also vital to foster and cultivate research talent and create an environment where pioneering clinical trials research can be developed. To do this, the Irish Cancer Society provide dedicated research buy-out time for oncology-based clinicians to allow them the time to develop new research ideas. Ultimately, we want people affected by cancer nationwide to have access to the best clinical research expertise.
Trials are the driving force behind improvements in cancer care and the hero of happy endings. We know that cancer research both in Ireland and globally lost valuable time during Covid — time that we can’t afford and need to catch up on as soon as possible.
To do this, we, as a community, all need to work together to do everything we can to ensure that people affected by cancer in Ireland have access to world-class clinical trials and expertise.
There is still time to support the Irish Cancer Society’s Daffodil Day by making a donation: cancer.ie
